Parkinsonism and tardive dyskinesia after chronic use of clebopride
✍ Scribed by A. P. Sempere; J. Duarte; J. M. Palomares; F. Coria; L. E. Clavería
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 234 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.
📜 SIMILAR VOLUMES
## Background: Chronically hospitalized geriatric inpatients with schizophrenia are at particular risk for both tardive dyskinesia (td) and cognitive impairment but have been insufficiently studied in this regard. similarly, the relationship between td and cognitive impairment has not be adequately
## Abstract Tardive dyskinesia (TD) occurs in approximately 20% of patients exposed to long‐term antipsychotic treatment and may be influenced by genetic predisposition, in addition to clinical risk factors. In this study, we implemented a two‐step approach to identify susceptibility genes for TD.
others were not. Like the patients described by Jansen Steur ( l ) , both of these patients had increases in finger tap scores, whereas unlike his patients, they had the induction or worsening of action tremor. In only one patient (patient 5 ) were symptoms of depression substantially ameliorated du
Drug-induced dyskinesias (DID) manifested as hyperkinetic and/or dystonic movements or postures are common problems in Parkinson's disease (PD). Novel therapeutic interventions may offer possibilities to counteract these common adverse effects of an otherwise necessary treatment. To be able to evalu